Stefan Alexander Wudy

Stefan Alexander Wudy

Auto-generated profile, based on publicly available information

Stefan Alexander Wudy

Pediatric Endocrinology and Diabetology, Center of Child and Adolescent Medicine, Justus Liebig University, 35392 Giessen, Germany

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
SWS.A. Wudy
S.A. Wudy
GSGerhard Schuler
Gerhard Schuler
ASA. Sánchez-Guijo
A. Sánchez-Guijo
MHM.F. Hartmann
M.F. Hartmann

1 October 2007 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
SWStefan A. Wudy
Stefan A. Wudy
MHMichaela F. Hartmann
Michaela F. Hartmann
TRThomas Remer
Thomas Remer
Detailed data on the physiological pattern of adrenocortical activity during normal growth are lacking. An established method to determine adrenocortical glucocorticoid secretion is the measurement of 24-h excretion rates of major urinary cortisol metabolites (C21). To test the hypothesis that the frequently reported higher cortisol secretion in men than in women develops during puberty, we examined C21 together with excretions of combined urinary free and conjugated cortisol (Fcomb) in 400 healthy boys and girls aged 3–18 yr using GC-MS. Daily excretion rates of C21, Fcomb, and body surface area (BSA)-corrected Fcombsignificantly increased with age in both sexes. In contrast, C21/BSA (μg·m−2·day−1) declined from the age of 3–4 yr to 7–8 yr in boys and girls ( P < 0.01; e.g., in boys: from 3,991 ± 1,167 to 3,193 ± 804), then increased in both sexes, and finally became discordant after the age of 11–12 yr with a further rise in males only (17- to 18-yr-olds: boys, 5,275 ± 1,414; girls 3,939 ± 1,586, P < 0.01). This pattern was associated with the occurrence of a lower index for 5α-reductase activity (allotetrahydrocortisol/tetrahydrocortisol) in females compared with males. Our results demonstrate dynamic changes in adrenocortical activity in healthy children resulting in an emerging sexual dimorphism in cortisol secretion after age 11. The latter can be explained, at least partly, by diverging 5α-reductase activities in boys and girls. Fcomb, a frequently analyzed GC-MS parameter, proved not to reflect dynamic changes in cortisol secretion. In conclusion, the varying metabolic need for cortisol during normal growth may have implications for future improvements in glucocorticoid replacement therapy.

1 May 2017 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
AKA Kulle
A Kulle
NKN Krone
N Krone
PHP M Holterhus
P M Holterhus
GSGerhard Schuler
Gerhard Schuler
RGRonda F Greaves
Ronda F Greaves
SWS A Wudy
S A Wudy
Disorders or differences in sex development (DSD) comprise a heterogeneous group of conditions with an atypical sex development. For optimal diagnosis, highly specialised laboratory analyses are required across European countries. Working group 3 of EU COST (European Cooperation in Science and Technology) Action BM 1303 ‘DSDnet’ ‘Harmonisation of Laboratory Assessment’ has developed recommendations on laboratory assessment for DSD regarding the use of technologies and analytes to be investigated. This position paper on steroid hormone analysis in diagnosis and treatment of DSD was compiled by a group of specialists in DSD and/or hormonal analysis, either from participating European countries or international partner countries. The topics discussed comprised analytical methods (immunoassay/mass spectrometry-based methods), matrices (urine/serum/saliva) and harmonisation of laboratory tests. The following positions were agreed upon: support of the appropriate use of immunoassay- and mass spectrometry-based methods for diagnosis and monitoring of DSD. Serum/plasma and urine are established matrices for analysis. Laboratories performing analyses for DSD need to operate within a quality framework and actively engage in harmonisation processes so that results and their interpretation are the same irrespective of the laboratory they are performed in. Participation in activities of peer comparison such as sample exchange or when available subscribing to a relevant external quality assurance program should be achieved. The ultimate aim of the guidelines is the implementation of clinical standards for diagnosis and appropriate treatment of DSD to achieve the best outcome for patients, no matter where patients are investigated or managed.

9 October 2020 in Science
Verified
Journal Article
Closed access
FRFrancisca M. Real
Francisca M. Real
SHStefan A. Haas
Stefan A. Haas
PFPaolo Franchini
Paolo Franchini
PXPeiwen Xiong
Peiwen Xiong
OSOleg Simakov
Oleg Simakov
DLDarío G. Lupiáñez
Darío G. Lupiáñez
Intersexuality in female moles: Female moles are intersexual and develop masculinizing ovotestes, a distinctive trait among mammals. Real et al. investigated the origin of this trait by sequencing the Iberian mole genome and applying comparative strategies that integrate transcriptomic, epigenetic, and chromatin interaction data. They identified mole-specific genomic rearrangements that alter the three-dimensional regulatory landscape of the androgen-converting gene CYP17A1 and the pro-testicular factor gene FGF9 , both of which show distinct expression patterns in mole gonads. The use of transgenic mice confirms the capability of these factors to increase circulating testosterone levels and to induce gonadal masculinization. This study highlights how integrative approaches can reveal the phenotypic impact of genomic variation. Science , this issue p. 208

1 July 2005 in Pediatrics
Verified
Journal Article
Open access
PDF file
SWStefan A. Wudy
Stefan A. Wudy
SHSandra Hagemann
Sandra Hagemann
ADAstrid Dempfle
Astrid Dempfle
GRGundula Ringler
Gundula Ringler
WBWerner F. Blum
Werner F. Blum
JHJohannes Hebebrand
Johannes Hebebrand
Objective. In children with idiopathic short stature (ISS), studies investigating body mass index (BMI) or parameters of satiety regulation are scarce, and studies analyzing eating behavior are lacking. Methods. We recruited 214 children (123 index cases and 91 siblings) with ISS from 123 families. Affected children had to have a body height <5th percentile, or, in the case of siblings, the body height of 1 child had to be <5th percentile and the other <15th percentile. Medical histories were recorded by using structured and standardized interviews. Eating behavior was assessed by using the Child Eating Behavior Questionnaire. Percent energy intake as fat was assessed by using the Leeds Food Frequency Questionnaire. Endocrine markers of body weight regulation (leptin, ghrelin) were determined in serum. Results. Compared with population norms, BMI was significantly lower (mean: −0.33 standard deviation score). Furthermore, there was decreased food responsiveness (mean Child Eating Behavior Questionnaire score: 1.9; population mean: 2.4), reduced enjoyment of food (3.2 vs 3.9), emotional undereating (2.6 vs 3.0), lower desire to drink (2.0 vs 2.8), and increased fussiness over food (3.2 vs 2.9). When the sample was subdivided into the 2 groups of “good” and “poor” eaters according to the mothers' assessment of the current eating behavior, reduction in BMI as well as the behavioral characteristics already delineated in the total sample were found to be even more consistent in the subgroup of poor eaters. In the total sample of our children, as well as in both subgroups, serum leptin (adjusted for gender, BMI, and Tanner stage) was found to be moderately raised but did not differ between poor and good eaters. Total serum ghrelin was not different between poor and good eaters. Conclusions. Our clinical, behavioral, and endocrinologic findings in patients with ISS point to an altered eating behavior that possibly contributes to their short stature.

1 June 2004 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
SWS. A. Wudy
S. A. Wudy
MHM. F. Hartmann
M. F. Hartmann
This review’s aim is to outline the potential of gas chromatography-mass spectrometry profiling of steroids in the diagnosis of endogenous human steroid disorders. Mass spectrometry currently provides the highest specificity in clinical steroid analysis. The non-invasive and non-selective GC-MS urinary steroid profiling technique enables diagnosis of almost any adrenal enzyme defects in steroid biosynthesis. While enzymatic defects can be diagnosed from spot urine samples in most cases, analysis of 24-hr urinary samples permits determination of hormonal excretion rates or enables diagnostic or therapeutic monitoring of steroid related diseases. Profiling plasma steroids by isotope dilution/GC-MS is particularly suitable where only minimal plasma samples are available and/or the highest specificity is required; therefore, GC-MS steroid profiling presents a complementary analytical technique whenever highest specificity is required. Clinical GC-MS profiling of steroids is also highly recommended as a reasonable initial diagnostic approach - especially in unclear situations - avoiding uncritical and expensive attempts at molecular diagnostic testing.